Patients in the clinical trials, who all have diabetes and/or obesity, also had fewer complaints about nausea and diarrhea
Most patients who stop GLP-1 therapy for 2 to 4 weeks experience modest weight rebound, typically 2 to 5 pounds, though individual responses vary
These gastrointestinal peptide hormones are not only effective in treating Type 2 diabetes, but they are also vital in weight management
En cuanto a los efectos secundarios, es cierto que, como en otros ensayos, las dosis ms altas tienden a ser las que producen ms efectos adversos
The science says no
[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Charidemou E., Ashmore T., Li X., McNally B.D., West J.A., Liggi S., Harvey M., Orford E., Griffin J.L